推薦: 檢驗(yàn)設(shè)備 | 影像設(shè)備 | 手術(shù)/急救設(shè)備 | 超聲設(shè)備 | 電子儀器 | 激光儀器 | 治療康復(fù)設(shè)備 | 病房護(hù)理設(shè)備 | 醫(yī)用光學(xué) | 冷療/冷藏設(shè)備 | 實(shí)驗(yàn)室設(shè)備 | 幻燈課件 | 臨床用藥 |
![]() |
|
首頁 > 美迪醫(yī)訊 > Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor |
Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor 【?2008-08-05 發(fā)布?】 美迪醫(yī)訊
Lipid Regulating Drugs and Anti-artherosclerosis Drugs ReportMarket Research Report On Lipid Regulating Drugs and Anti-artherosclerosis Drugs
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,500
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
First part: Epidemiology of hyperlipemia
1 Conception of hyperlipemia
2 Types of hyperlipemia
3 Epidemiology of hyperlipemia in China
3.1 Chinese blood-lipid level and distribution feature
3.2 Morbidity rate
4 Catergories and product structure
5 Overview of Health food for lipids regulating
Second part: Market analysis
1 Market scale and growth trend of cardiovascular drugs
2 Overview about lipids regulating drugs marekt
2.1 Academic market capacity
2.2 Overview about hospital market and retail market
3 Analysis about hospital market
3.1 Growth trend of lipids regulating drugs in the past few years
3.2 Market shares of different categories
3.3 Sales rank of breeds of lipids regulating drugs last year
3.4 Sales analysis in key cities
3.5 Sales analysis of Statin drugs
3.5.1 Simvastatin(Zocor)
3.5.2 Lovastatin(Mevacor)
3.5.3 Pravastatin
3.5.4 Fluvastatin(Lescol)
3.5.5 Atorvastatin
3.5.6 Rosuvastatin
3.5.7 Compound preparation of Statins
ezetimibe/Simvastatin (Vytorin)
Torcetrapib/Atorvastatin
MK-0524A/Zocor
Statins+cholalic acid chelating agent
Other compound preparation of Statins
3.6 Fibrates
3.6.1 Fenofibrate
3.6.2 Gemfibrozil
3.7 Nicotinic Acid class
3.7.1 Tocopheryl Nicotinate
3.7.2 Acipimox
3.8 Prepared Chinese Medicine
3.8.1 "ZhiBiTuo"
3.8.2 "XueZhiKang"
3.8.3 Gypenosides
3.9 Heparins class
3.9.1 Chondroitin A
3.9.2 Alginic Sodium Diester
3.9.3 Mannose Ester
3.10 Polyunsaturated fatty acid class
3.10.1 Ethyl Polyenoate
3.10.2 Squalene
3.10.3 Linoleic acid compound
3.10.4 Evening primrose oil
3.11 Analysis about manufacturing enterprises
3.11.1 Market share of procucts made by domestic, foreign, joint venture enterprises
3.11.2 Top 15 manufacturing enterprising last year
4 Analysis about retail market
4.1 Market shares of different categories
4.2 Sales rank of breeds of lipids regulating drugs
4.3 Sales shares of different enterprises
4.3.1 Statins
4.3.2 Prepared Chinese Medicine
4.3.3 Fibrates
4.3.4 Polyunsaturated fatty acid class
4.3.5 Nicotinic Acid class
4.4 Enterprise list ranked by sales value
4.5 Top 15 enterpsies ranked by sales value in different cities
4.5.1 Beijing
4.5.2 Shanghai
4.5.3 Guangzhou
4.5.4 Wuhan
4.5.5 Shenyang
4.5.6 chengdu
4.5.7 hangzhou
4.5.8 Shenzhen
4.5.9 Shijiazhuang
4.5.10 Zhengzhou
本文關(guān)鍵字:
《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務(wù)咨詢: 美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢
《上海醫(yī)療器械批發(fā)》產(chǎn)品推薦
|
合作支持:中華醫(yī)學(xué)會(huì) | 中華醫(yī)院管理學(xué)會(huì) | 國家食品藥品監(jiān)督管理家用護(hù)理器械商城 | 國藥勵(lì)展展覽有限責(zé)任公 | 醫(yī)學(xué)裝備協(xié)會(huì) |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關(guān)于美迪 | 法律聲明 | 隱私保護(hù) | 網(wǎng)站地圖 |
把美迪網(wǎng)放進(jìn)收藏夾 把美迪醫(yī)療網(wǎng)介紹給我的朋友 給美迪醫(yī)療網(wǎng)留言
美迪醫(yī)療網(wǎng)廣告業(yè)務(wù)聯(lián)系:021-51601230 產(chǎn)品咨詢業(yè)務(wù)聯(lián)系:021-51601230 傳真:021-56532303 ![]() 互聯(lián)網(wǎng)藥品信息服務(wù)許可證:(滬)-經(jīng)營性-2009-0003 中華人民共和國電信與信息服務(wù)業(yè)務(wù)經(jīng)營許可證:(滬)B2-20090029 ![]() ![]() ![]() 公安備案號(hào) 31010602000199 醫(yī)療器械經(jīng)營許可證: 滬靜藥監(jiān)械經(jīng)營許20210003號(hào) 第二類醫(yī)療器械經(jīng)營備案憑證: 滬靜藥監(jiān)械經(jīng)營備20220042號(hào) 營業(yè)執(zhí)照:統(tǒng)一社會(huì)信用代碼91310108676284138X互聯(lián)網(wǎng)藥品信息服務(wù)資格書:(滬)-非經(jīng)營性-2023-0081 |